1151 related articles for article (PubMed ID: 33732263)
21. miRNA-146a Improves Immunomodulatory Effects of MSC-derived Exosomes in Rheumatoid Arthritis.
Tavasolian F; Hosseini AZ; Soudi S; Naderi M
Curr Gene Ther; 2020; 20(4):297-312. PubMed ID: 32938348
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis.
Ma D; Xu K; Zhang G; Liu Y; Gao J; Tian M; Wei C; Li J; Zhang L
Int Immunopharmacol; 2019 Sep; 74():105687. PubMed ID: 31295689
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies.
Lopez-Santalla M; Bueren JA; Garin MI
EBioMedicine; 2021 Jul; 69():103427. PubMed ID: 34161884
[TBL] [Abstract][Full Text] [Related]
24. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus.
Zhu Y; Feng X
Stem Cell Res Ther; 2018 May; 9(1):149. PubMed ID: 29793537
[TBL] [Abstract][Full Text] [Related]
25. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis.
Shin TH; Kim HS; Kang TW; Lee BC; Lee HY; Kim YJ; Shin JH; Seo Y; Won Choi S; Lee S; Shin K; Seo KW; Kang KS
Cell Death Dis; 2016 Dec; 7(12):e2524. PubMed ID: 28005072
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis.
Sarsenova M; Issabekova A; Abisheva S; Rutskaya-Moroshan K; Ogay V; Saparov A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769021
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder.
Fathollahi A; Gabalou NB; Aslani S
Lupus; 2018 Jun; 27(7):1053-1064. PubMed ID: 29631514
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE.
Wong C; Stoilova I; Gazeau F; Herbeuval JP; Fourniols T
Front Immunol; 2024; 15():1355845. PubMed ID: 38390327
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response.
Luque-Campos N; Contreras-López RA; Jose Paredes-Martínez M; Torres MJ; Bahraoui S; Wei M; Espinoza F; Djouad F; Elizondo-Vega RJ; Luz-Crawford P
Front Immunol; 2019; 10():798. PubMed ID: 31040848
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor signalling associated with immunomodulation of umbilical cord-derived mesenchymal stem cells in mice with systemic lupus erythematosus.
Wu KH; Cheng CC; Li JP; Weng TF; Yang SF; Pan HH; Chao YH
Lupus; 2020 Feb; 29(2):165-175. PubMed ID: 31964222
[TBL] [Abstract][Full Text] [Related]
31. Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases.
Shen Z; Huang W; Liu J; Tian J; Wang S; Rui K
Front Immunol; 2021; 12():749192. PubMed ID: 34646275
[TBL] [Abstract][Full Text] [Related]
32. The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis.
Miranda JP; Camões SP; Gaspar MM; Rodrigues JS; Carvalheiro M; Bárcia RN; Cruz P; Cruz H; Simões S; Santos JM
Front Immunol; 2019; 10():18. PubMed ID: 30804924
[TBL] [Abstract][Full Text] [Related]
33. Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases.
Jasim SA; Yumashev AV; Abdelbasset WK; Margiana R; Markov A; Suksatan W; Pineda B; Thangavelu L; Ahmadi SH
Stem Cell Res Ther; 2022 Mar; 13(1):101. PubMed ID: 35255979
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.
Xu J
Adv Exp Med Biol; 2018; 1089():73-85. PubMed ID: 29767288
[TBL] [Abstract][Full Text] [Related]
35. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
36. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
Bouffi C; Djouad F; Mathieu M; Noël D; Jorgensen C
Rheumatology (Oxford); 2009 Oct; 48(10):1185-9. PubMed ID: 19561159
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus.
Sui W; Hou X; Che W; Chen J; Ou M; Xue W; Dai Y
Clin Immunol; 2013 Aug; 148(2):186-97. PubMed ID: 23770628
[TBL] [Abstract][Full Text] [Related]
38. Natural products action on pathogenic cues in autoimmunity: Efficacy in systemic lupus erythematosus and rheumatoid arthritis as compared to classical treatments.
Cao F; Cheng MH; Hu LQ; Shen HH; Tao JH; Li XM; Pan HF; Gao J
Pharmacol Res; 2020 Oct; 160():105054. PubMed ID: 32645358
[TBL] [Abstract][Full Text] [Related]
39. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
[TBL] [Abstract][Full Text] [Related]
40. Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.
Zhang H; Zeng X; Sun L
Expert Opin Biol Ther; 2010 May; 10(5):701-9. PubMed ID: 20345339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
